FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 

RELATED ARTICLES

Mouse Model of Human Immune System Inadequate for Stem Cell Studies

News

“Humanized” mice are used to study human immune responses, but they are inadequate for stem cell studies, say Stanford researchers. Optimized models are needed for clinical decision-making.

READ MORE

New Test for Rare Immunodeficiency

News

Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency.

READ MORE

Pre-Clinical Piglets Reveal Gut-Brain Link Via Cortisol

News

Researchers suggest a pathway of communication between certain gut bacteria and brain metabolites, by way of the stress hormone cortisol.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE